Question
What will be the vaccine efficacy of the two-dose Johnson & Johnson Ad26.COV2.S vaccine candidate according to the results of Phase III testing?
Total Forecasters24
Community Prediction
89.8
(82.6 - 94.5)
Make a Prediction
CDF
This question is closed for predictions, and is waiting to be resolved
| Quartiles | community | My Prediction |
| lower 25% | 82.61 | — |
| median | 89.82 | — |
| upper 75% | 94.5 | — |
Authors:
Opened:Mar 12, 2021
Closed:Oct 4, 2021
Scheduled resolution:Feb 1, 2026
Spot Scoring Time:Mar 14, 2021
Authors:
Opened:Mar 12, 2021
Closed:Oct 4, 2021
Scheduled resolution:Feb 1, 2026
Spot Scoring Time:Mar 14, 2021